tetano
Editor, Senior Moderator
PLoS One
. 2022 Jul 14;17(7):e0271463.
doi: 10.1371/journal.pone.0271463. eCollection 2022.
SARS-CoV-2 spike and nucleocapsid proteins fail to activate human dendritic cells or γδ T cells
Kiran Singh[SUP] 1 [/SUP], Sita Cogan[SUP] 1 [/SUP], Stefan Elekes[SUP] 1 [/SUP], Dearbhla M Murphy[SUP] 1 [/SUP], Sinead Cummins[SUP] 1 [/SUP], Rory Curran[SUP] 1 [/SUP], Zaneta Najda[SUP] 2 [/SUP], Margaret R Dunne[SUP] 1 [/SUP], Gráinne Jameson[SUP] 1 [/SUP], Siobhan Gargan[SUP] 3 [/SUP], Seamus Martin[SUP] 2 [/SUP], Aideen Long[SUP] 3 [/SUP], Derek G Doherty[SUP] 1 [/SUP]
Affiliations
Abstract
γδ T cells are thought to contribute to immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mechanisms by which they are activated by the virus are unknown. Using flow cytometry, we investigated if the two most abundant viral structural proteins, spike and nucleocapsid, can activate human γδ T cell subsets, directly or in the presence of dendritic cells (DC). Both proteins failed to induce interferon-γ production by Vδ1 or Vδ2 T cells within fresh mononuclear cells or lines of expanded γδ T cells generated from healthy donors, but the same proteins stimulated CD3+ cells from COVID-19 patients. The nucleocapsid protein stimulated interleukin-12 production by DC and downstream interferon-γ production by co-cultured Vδ1 and Vδ2 T cells, but protease digestion and use of an alternative nucleocapsid preparation indicated that this activity was due to contaminating non-protein material. Thus, SARS-CoV-2 spike and nucleocapsid proteins do not have stimulatory activity for DC or γδ T cells. We propose that γδ T cell activation in COVID-19 patients is mediated by immune recognition of viral RNA or other structural proteins by γδ T cells, or by other immune cells, such as DC, that produce γδ T cell-stimulatory ligands or cytokines.
. 2022 Jul 14;17(7):e0271463.
doi: 10.1371/journal.pone.0271463. eCollection 2022.
SARS-CoV-2 spike and nucleocapsid proteins fail to activate human dendritic cells or γδ T cells
Kiran Singh[SUP] 1 [/SUP], Sita Cogan[SUP] 1 [/SUP], Stefan Elekes[SUP] 1 [/SUP], Dearbhla M Murphy[SUP] 1 [/SUP], Sinead Cummins[SUP] 1 [/SUP], Rory Curran[SUP] 1 [/SUP], Zaneta Najda[SUP] 2 [/SUP], Margaret R Dunne[SUP] 1 [/SUP], Gráinne Jameson[SUP] 1 [/SUP], Siobhan Gargan[SUP] 3 [/SUP], Seamus Martin[SUP] 2 [/SUP], Aideen Long[SUP] 3 [/SUP], Derek G Doherty[SUP] 1 [/SUP]
Affiliations
- PMID: 35834480
- DOI: 10.1371/journal.pone.0271463
Abstract
γδ T cells are thought to contribute to immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mechanisms by which they are activated by the virus are unknown. Using flow cytometry, we investigated if the two most abundant viral structural proteins, spike and nucleocapsid, can activate human γδ T cell subsets, directly or in the presence of dendritic cells (DC). Both proteins failed to induce interferon-γ production by Vδ1 or Vδ2 T cells within fresh mononuclear cells or lines of expanded γδ T cells generated from healthy donors, but the same proteins stimulated CD3+ cells from COVID-19 patients. The nucleocapsid protein stimulated interleukin-12 production by DC and downstream interferon-γ production by co-cultured Vδ1 and Vδ2 T cells, but protease digestion and use of an alternative nucleocapsid preparation indicated that this activity was due to contaminating non-protein material. Thus, SARS-CoV-2 spike and nucleocapsid proteins do not have stimulatory activity for DC or γδ T cells. We propose that γδ T cell activation in COVID-19 patients is mediated by immune recognition of viral RNA or other structural proteins by γδ T cells, or by other immune cells, such as DC, that produce γδ T cell-stimulatory ligands or cytokines.